Lates News

According to AI Quick News, Huayuan Securities issued a research report on April 22 giving a "buy" rating to Meihao Medical (301363.SZ). The rating reasons mainly include: 1) The growth of new medical devices is impressive, and global production capacity has been strengthened; 2) The gross profit margin has been slightly adjusted, and active layout in the forefront business of brain-computer interface. (Daily Economic News)